[18F]haloperidol binding in baboon brain in vivo

Nuclear Medicine and Biology

Volumn 23, Issue 1, 1996, Pages 47-52

  Yousef, Khalil A ^a   Fowler, Joanna S ^a   Volkow, Nora D ^a   Dewey, Stephen L ^a   Shea, Colleen ^a   Schlyer, David J ^a   Gatley, S John ^a   Logan, Jean ^a   Wolf, Alfred P ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Dopamine D2 receptors; PET; Sigma binding sites; 18F haloperidol

Indexed keywords

DOPAMINE 2 RECEPTOR; FLUORINE 18; HALOPERIDOL;

ANIMAL EXPERIMENT; ARTICLE; BABOON; BRAIN; CONTROLLED STUDY; POSITRON EMISSION TOMOGRAPHY;

EID: 0029671396     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02014-4     Document Type: Article

References (34)

1. 18F-labeled butyrophenone neuroleptic drugs in the baboon using positron emission tomography. J. Neurochem. 44, 835-844.
2. Black J. L. (1987) Antipsychotic drugs: Prediction of side-effect profiles based on neuroreceptor data derived from human brain tissue. Mayo Clin. Proc. 62, 369-372.
3. 3H]haloperidol in rat brain. Neuroscience Lett. 75, 133-140.
4. 11C-methyl]-benztropine. Synapse 5, 213-223.
5. 18F]BMY 14802, a potential antipsychotic drug. J. Nucl. Med. 34, 246-254.
6. Farde L., Wiesel F. A., Halldin C. and Sedvall G. (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry 45, 71-76.
7. Fowler J. S., Wolf A. P. and Volkow N. D. (1990) New directions in positron emission tomography - Part II. Ann. Reports in Med. Chem. 25, 261-269.
8. 11C]ketamine in the rhesus monkey studied by positron emission tomography (PET). Nucl. Med. Biol. 21, 927-934.
9. 3H]spiperone binding sites in various areas of rat limbic system. Mol. Pharm. 15, 506-514.
10. Kessler R. M., Mason N. S., Votaw J. R., dePaulis T., Clanton J. A., Ansari M. S., Schmidt D. E., Manning R. G. and Bell R. L. (1992) Visualization of extrastriatal dopamine D2 receptors in the human brain. Eur. J. Pharmacol. 223, 105-107.
11. 125I]epidepride. Brain Res. 609, 237-243.
12. Laduron P. M., Janssen P. F. M. and Leysen J. E. (1978) Spiperone: A ligand of choice for neuroleptic receptors. Biochem. Pharmacol. 27, 317-321.
13. 3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc. Nat. Acad. Sci. USA. 81, 4983-4987.
14. 3H ligand for serotonin receptor binding sites. Binding properties, brain distribution and functional role. Mol. Pharm. 21, 301-314.
15. Mash D. C. and Zabetian C. P. (1992) Sigma receptors are associated with cortical limbic areas in the primate brain. Synapse 12, 195-205.
16. Musachio J. L., Scheffel U., Stathis M., Ravert H. T., Mathews W. B. and Dannals R. F. (1994) (+)-[C-11]-cis-N-benzyl-normetazocine: A selective ligand for sigma receptors in vivo. Life Sci. 55, PL 225-232.
17. Oliviera C. R., Lima M. C. P., Carvalho, C. A. M., Leysen J. E. and Carvalho A. P. (1989) Partition coefficients of dopamine agonists in brain membranes and liposomes. Biochem. Pharmacol. 38, 2113-2120.
18. Rayport S. and Sulzer D. (1995) Visualization of antipsychotic drug binding to living mesolimbic neurons reveals D2 receptor. acidotropic and lipophilic components. J. Neurochem. 65, 691-703.
19. 18F]haloperidol. Synapse 11, 10-19.
20. Schmalzing G. (1988) The role of a transmembrane pH gradient in uptake and release of imipramine and haloperidol in synaptosomes. Mol. Pharmacol. 34, 888-895.
21. Seeman P. (1972) The membrane actions of anesthetics and tranquilizers. Pharmacol. Rev. 24, 583-655.
22. Seeman P. and Lee T. (1975) Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188, 1217-1219.
23. 18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug 132 receptor occupancy in schizophrenic patients. Biol. Psych. 23, 653-663.
24. 3H]SKF 10.047, (+)-[3H]ethylketocyclazocine, μ, κ, δ and phencyclidine binding sites in guinea pig brain membranes. Eur. J Pharmacol. 109, 33-41.
25. 3H]haloperidol binding in guinea pig membranes. Proc. Natl. Acad. Sci. USA 481, 5618-5621.
26. 18F]haloperidol: A radioligand for in vivo studies of the dopamine receptors. Brain Res. 192, 291-295.
27. 3H]1-(cyclopropylmethyl)-4-(2-(4-fluorophenyl)-2-oxoethyl)piperidine HBr (DuP 734). A selective ligand for sigma receptors in mouse brain in vivo. J. Pharmacol. Exp. Ther. 266, 1541-1548.
28. 3H]haloperidol to sigma receptors in the mouse brain. J. Chem. Neuroanatomy 3, 1-8.
29. Weissmann A. D., Su T. P., Hedreen J. C. and London E. (1988) Sigma receptors in post mortem human brains. J. Pharm. Exp. Ther. 247, 29-33.
30. 18F-haloperidol: Potential agents for imaging the dopamine receptor. Life Sci. 33, 1687-1693.
31. Wong D. F., Gibson R., Burns H. D., Dannals R. F., Shaya E., London E. D., Brenner N., Wilson A. A., Ravert H. T., Chen C., Minkin E. and Wagner H. N. (1991) In vivo imaging of sigma receptors in primate brain. J. Nucl. Med. 32, 1071.
32. Wong D. F., Gjedde A., Wagner H. N., Dannals R. F., Douglass K. H., Links J. M. and Kuhar M. J. (1986) Quantification of neuroreceptors in the living human brain II. Inhibition studies of receptor density and affinity. J. Cereb. Blood Flow Metab. 6, 147-153.
33. Wysowski A. D. and Baum C. (1989) Antipsychotic drug use in the United States 1976-1985. Arch. Gen. Psychiatry 46, 929-932.
34. 18F]N-methylspiroperidol by extrastriatal dopamine receptors in schizophrenic patients. Synapse 19, 14-17.